These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28783690)

  • 1. Cross-talk between iNKT cells and monocytes triggers an atheroprotective immune response in SLE patients with asymptomatic plaque.
    Smith E; Croca S; Waddington KE; Sofat R; Griffin M; Nicolaides A; Isenberg DA; Torra IP; Rahman A; Jury EC
    Sci Immunol; 2016 Dec; 1(6):. PubMed ID: 28783690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells.
    Bosma A; Abdel-Gadir A; Isenberg DA; Jury EC; Mauri C
    Immunity; 2012 Mar; 36(3):477-90. PubMed ID: 22406267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of invariant natural killer T cells in lupus and atherogenesis.
    Major AS; Singh RR; Joyce S; Van Kaer L
    Immunol Res; 2006; 34(1):49-66. PubMed ID: 16720898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?
    Smyk DS; Mavropoulos A; Mieli-Vergani G; Vergani D; Lenzi M; Bogdanos DP
    Can J Gastroenterol Hepatol; 2018; 2018():8197937. PubMed ID: 30046564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.
    Godó M; Sessler T; Hamar P
    Curr Med Chem; 2008; 15(18):1778-87. PubMed ID: 18691038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE.
    Liu F; Fan H; Ren D; Dong G; Hu E; Ji J; Hou Y
    Eur J Immunol; 2015 Jul; 45(7):1934-45. PubMed ID: 25929465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory function of invariant natural killer T cells in systemic lupus erythematosus.
    Chuang YP; Wang CH; Wang NC; Chang DM; Sytwu HK
    Clin Dev Immunol; 2012; 2012():478429. PubMed ID: 22761630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of iNKT cells in the immunopathology of systemic lupus erythematosus.
    Gabriel L; Morley BJ; Rogers NJ
    Ann N Y Acad Sci; 2009 Sep; 1173():435-41. PubMed ID: 19758183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant presentation of self-lipids by autoimmune B cells depletes peripheral iNKT cells.
    Tan AH; Chong WP; Ng SW; Basri N; Xu S; Lam KP
    Cell Rep; 2014 Oct; 9(1):24-31. PubMed ID: 25263549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined proinflammatory cytokine and cognate activation of invariant natural killer T cells enhances anti-DNA antibody responses.
    Sedimbi SK; Hägglöf T; Garimella MG; Wang S; Duhlin A; Coelho A; Ingelshed K; Mondoc E; Malin SG; Holmdahl R; Lane DP; Leadbetter EA; Karlsson MCI
    Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9054-9063. PubMed ID: 32295878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis.
    Kyriakakis E; Cavallari M; Andert J; Philippova M; Koella C; Bochkov V; Erne P; Wilson SB; Mori L; Biedermann BC; Resink TJ; De Libero G
    Eur J Immunol; 2010 Nov; 40(11):3268-79. PubMed ID: 21061446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinflammatory Differentiation of Macrophages Through Microparticles That Form Immune Complexes Leads to T- and B-Cell Activation in Systemic Autoimmune Diseases.
    Burbano C; Villar-Vesga J; Vásquez G; Muñoz-Vahos C; Rojas M; Castaño D
    Front Immunol; 2019; 10():2058. PubMed ID: 31555283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein.
    Das R; Guan P; Wiener SJ; Patel NP; Gohl TG; Evans E; Zauderer M; Nichols KE
    Blood Adv; 2019 Mar; 3(5):813-824. PubMed ID: 30858151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Invariant Natural Killer T Cells Respond to Antigen-Presenting Cells Exposed to Lipids from Olea europaea Pollen.
    Abos Gracia B; López Relaño J; Revilla A; Castro L; Villalba M; Martín Adrados B; Regueiro JR; Fernández-Malavé E; Martínez Naves E; Gómez Del Moral M
    Int Arch Allergy Immunol; 2017; 173(1):12-22. PubMed ID: 28486236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.
    Yang JQ; Wen X; Liu H; Folayan G; Dong X; Zhou M; Van Kaer L; Singh RR
    Arthritis Rheum; 2007 Apr; 56(4):1219-33. PubMed ID: 17393451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
    Forestier C; Molano A; Im JS; Dutronc Y; Diamond B; Davidson A; Illarionov PA; Besra GS; Porcelli SA
    J Immunol; 2005 Jul; 175(2):763-70. PubMed ID: 16002672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors.
    Guo T; Chamoto K; Nakatsugawa M; Ochi T; Yamashita Y; Anczurowski M; Butler MO; Hirano N
    PLoS One; 2016; 11(5):e0156114. PubMed ID: 27213277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease in systemic lupus erythematosus: an update.
    Liu Y; Kaplan MJ
    Curr Opin Rheumatol; 2018 Sep; 30(5):441-448. PubMed ID: 29870498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunometabolic Activation of Invariant Natural Killer T Cells.
    Ververs FA; Kalkhoven E; Van't Land B; Boes M; Schipper HS
    Front Immunol; 2018; 9():1192. PubMed ID: 29892305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte antigen-presenting capacity to iNKT cells is influenced by the blood collection conditions.
    Borges SM; Santos C; Macedo MF
    J Immunol Methods; 2023 Feb; 513():113426. PubMed ID: 36638882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.